Farrerol

Farrerol

SCHEMBL28048308

Cc1c(O)c(C)c2c(c1O)C(=O)C[C@@H](c1ccc(O)cc1)O2

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.71
ESR2 Q92731 8/20 0.71
MEN1 O00255 2/20 0.64
POLB P06746 2/20 0.64
KMT2A Q03164 2/20 0.64
APEX1 P27695 1/20 0.64
RECQL P46063 1/20 0.64
CACNA1B Q00975 1/20 0.64
APBA1 Q02410 1/20 0.64
MCL1 Q07820 1/20 0.64
CTDSP1 Q9GZU7 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
MAPT P10636 1/20 0.57
XBP1 P17861 1/20 0.57
GUSB P08236 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Farrerol SCHEMBL928045 1.00 ESR1 (0.71) ESR1ESR2MEN1POLBKMT2A
SCHEMBL11120379 0.89 ESR1 (0.57) ESR1ESR2MEN1POLBKMT2A
Demethoxymatteucinol SCHEMBL29204370 0.89 ABCG2 (0.64) ESR1ESR2MEN1POLBKMT2A
Demethoxymatteucinol SCHEMBL664144 0.89 ABCG2 (0.64) ESR1ESR2MEN1POLBKMT2A
SCHEMBL7543177 0.87 CYP1A1 (0.57) ESR1ESR2MEN1POLBKMT2A
SCHEMBL29776987 0.87 CYP1A1 (0.57) ESR1ESR2MEN1POLBKMT2A
SCHEMBL1201860 0.87 ESR1 (0.55) ESR1ESR2MEN1POLBKMT2A
SCHEMBL1200443 0.87 ESR1 (0.55) ESR1ESR2MEN1POLBKMT2A
Cyrtominetin SCHEMBL1201687 0.85 POLB (0.62) ESR1ESR2MEN1POLBKMT2A
Cyrtominetin SCHEMBL29657275 0.85 POLB (0.62) ESR1ESR2MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087918-A1 GLAZING HAVING A CONNECTOR PILKINGTON GROUP LIMITED (GB) 2026-04-30 WO disclosed
WO-2024155942-A1 RAPID DEVELOPMENT OF AFFORDABLE, ARTIFICIAL POSITIVE CONTROLS THAT MIMIC PATHOGEN TITER AND TROPISM THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 2024-07-25 WO disclosed
CN-115501223-B Application of azalea essence in preparing medicine for resisting cerebral ischemia reperfusion injury 青岛大学 2024-01-16 CN disclosed
CN-115501223-A Application of farrerol in preparation of medicine for resisting cerebral ischemia reperfusion injury 青岛大学 2022-12-23 CN disclosed
CN-105560996-A Pharmaceutical composition for treating dental ulcer and preparation method thereof JINAN XINGYI MED TECH CO LTD 2016-05-11 CN disclosed
CN-105168440-A Pharmaceutical composition used for preventing gout JINAN XINGYI MED TECH CO LTD 2015-12-23 CN disclosed